Nomura Holdings’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
VPM
QCM
VCM
NAMA
Nomura Holdings's TXG Position: Q1 2026 in Review
Nomura Holdings reduced its 10x Genomics (TXG) stake by 76% in Q1 2026, selling an estimated $4.97M and leaving 77,036 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #990.
Nomura Holdings first reported a position in TXG in Q4 2022 and has held it in 4 quarters since. The position peaked at $5.31M in Q4 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.
- Nomura Holdings held 77,036 shares of 10x Genomics worth $1.64M as of Q1 2026.
- Nomura Holdings sold 248,747 10x Genomics shares in Q1 2026, an estimated $4.97M.
- 10x Genomics made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #990 holding.
- Nomura Holdings first reported a position in 10x Genomics in Q4 2022 and has held it in 4 quarters since.
- Nomura Holdings's 10x Genomics position peaked at $5.31M in Q4 2025.
- 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.